555

WAVERLEY PHARMA INC.

No trades
See on Supercharts
Market capitalization
‪919.21 K‬EUR
−0.0140EUR
‪−457.73 K‬EUR
‪859.41 K‬EUR
‪13.61 M‬
Beta (1Y)
−2.02

About WAVERLEY PHARMA INC.

CEO
Larry Thiessen
Headquarters
Winnipeg
Founded
2014
ISIN
CA94357L1058
FIGI
BBG00X9DLZ62
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WAVERLEY PHARMA INC. stocks are traded under the ticker 5GZ.
Yes, you can track WAVERLEY PHARMA INC. financials in yearly and quarterly reports right on TradingView.
No, 5GZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 5GZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WAVERLEY PHARMA INC. stock right from TradingView charts — choose your broker and connect to your account.
5GZ reached its all-time high on Feb 16, 2021 with the price of 0.1530 EUR, and its all-time low was 0.0065 EUR and was reached on Feb 2, 2024.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WAVERLEY PHARMA INC. EBITDA is ‪−513.29 K‬ EUR, and current EBITDA margin is −42.54%. See more stats in WAVERLEY PHARMA INC. financial statements.